Efficacy News and Research

RSS
Zafgen announces new data from two Phase 1 studies of beloranib on obesity

Zafgen announces new data from two Phase 1 studies of beloranib on obesity

Sanofi’s Lantus more effective than sitagliptin for people with type 2 diabetes

Sanofi’s Lantus more effective than sitagliptin for people with type 2 diabetes

Cebix announces data from Ersatta Phase 1 study on type 1 diabetes

Cebix announces data from Ersatta Phase 1 study on type 1 diabetes

JCAD publishes results from clincal study of Tria Skin Perfecting Blue Light for acne

JCAD publishes results from clincal study of Tria Skin Perfecting Blue Light for acne

Positive results from Amgen Sensipar/Mimpara Phase 3 trial for HPT, CKD

Positive results from Amgen Sensipar/Mimpara Phase 3 trial for HPT, CKD

Accuray announces outcome data from CyberKnife Prostate SBRT study

Accuray announces outcome data from CyberKnife Prostate SBRT study

WHO identifies best targets for seasonal malaria treatment

WHO identifies best targets for seasonal malaria treatment

Data from abatacept versus adalimumab Phase IIIb comparison study on RA

Data from abatacept versus adalimumab Phase IIIb comparison study on RA

NCI presents long-term outcomes from BiovaxID lymphoma vaccine Phase II trial at ASCO 2012

NCI presents long-term outcomes from BiovaxID lymphoma vaccine Phase II trial at ASCO 2012

MGH, HSG to conduct PBT2 clinical trial in Huntington's disease

MGH, HSG to conduct PBT2 clinical trial in Huntington's disease

BRF to fund research that focuses on sports-related concussive injuries among young children

BRF to fund research that focuses on sports-related concussive injuries among young children

FDA approves XenoPort, GSK’s Horizant ER tablets for management of PHN

FDA approves XenoPort, GSK’s Horizant ER tablets for management of PHN

Enrollment complete in Advaxis’ ADXS-HPV Phase 2 study on CIN 2/3

Enrollment complete in Advaxis’ ADXS-HPV Phase 2 study on CIN 2/3

Clinical study shows positive effects of CAD106 vaccine against AD

Clinical study shows positive effects of CAD106 vaccine against AD

WIN Symposium to take place in Paris from June 28-29

WIN Symposium to take place in Paris from June 28-29

Plasma levels of tau appear to be a strong predictor for AD

Plasma levels of tau appear to be a strong predictor for AD

Debiopharm announces results from Debio 0932 Phase I study on cancer

Debiopharm announces results from Debio 0932 Phase I study on cancer

ProFibrix initiates Phase III trial with Fibrocaps in spine, liver, vascular and soft tissue surgery

ProFibrix initiates Phase III trial with Fibrocaps in spine, liver, vascular and soft tissue surgery

Roundup: Calif. cigarette tax hike too close to call; Mass. insurance mandate not as contentious; Sept. 11 health fund cancer coverage ruling delayed

Roundup: Calif. cigarette tax hike too close to call; Mass. insurance mandate not as contentious; Sept. 11 health fund cancer coverage ruling delayed

Split-course RT valuable after hormone-resistant prostate cancer relapse

Split-course RT valuable after hormone-resistant prostate cancer relapse

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.